Ethical conduct is paramount in cancer research. Sponsors must obtain informed consent from all study participants, ensuring that they are fully aware of the risks and benefits associated with the trial. They must also ensure that the study has been reviewed and approved by an independent Institutional Review Board (IRB) or Ethics Committee.
